Pediatric research is essential to improving child health worldwide. However, scientific, ethical, and infrastructural challenges serve as barriers to this essential research. International and national stakeholders have developed coordinated strategies to strengthen evidence generation, enhance safety assessments, and accelerate therapeutic discovery for children.
According to the authors of this Letter to the Editor, ensuring robust female representation in both clinical and observational studies is vital for producing generalizable findings and improving women’s health. Despite significant efforts to include women and minorities in clinical research, persistent gaps in participation still exist. A key challenge lies in balancing participation with safety measures designed to protect female participants, particularly those of childbearing potential, from the risks associated with certain inventions and/or exposures.
While risk-based quality management has gained increasing acceptance across the clinical research enterprise, quantitative evidence on its financial impact has been limited. A new analysis coauthored by experts from CluePoints and the Tufts Center for the Study of Drug Development addresses this gap.
If one takes the view that the tenets of patient centricity in healthcare include supporting not only patients but also the people who stand closest to them, then supporting the clinical research coordinators (CRCs) who have the most patient-facing role in clinical trials should be a critical focus, according to the creator of an award-winning poster presented earlier this year at ACRP 2026 in Orlando.
No one is saying that clinical trial sites, sponsors, and contract research organizations (CROs) can’t symbolically gather 'round the campfire and get along with one another. In fact, they can and must, if the clinical research enterprise is to keep running on all cylinders. So it is that, in the forthcoming August issue of Clinical Researcher, we consider the theme of “Better Together: Getting Sites, Sponsors, and CROs All on the Same Page” by way of a variety of contributors who address the nuances of these potentially rewarding and potentially fraught ties between research partners.